Ceftaroline in the treatment of concomitant methicillin-resistant and daptomycin-non-susceptible staphylococcus aureus infective endocarditis and osteomyelitis: Case report

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 6, 2013, Pages

  Jongsma, Karissa ^a   Joson, Jeremiah ^a   Heidari, Arash ^a  

^a KERN MEDICAL CENTER   (United States)

Author keywords

Abscess; Intravenous drug user; salvage therapy; Surgery

Indexed keywords

CEFTAROLINE; DAPTOMYCIN; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; VANCOMYCIN; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE;

ABSCESS DRAINAGE; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL ENDOCARDITIS; BLOOD CULTURE; BROTH DILUTION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONCURRENT INFECTION; DEBRIDEMENT; DRUG MEGADOSE; DRUG TREATMENT FAILURE; EPSILOMETER TEST; FEVER; HIP PAIN; HUMAN; LEUKOCYTOSIS; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MIDDLE AGED; MINIMUM INHIBITORY CONCENTRATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMYELITIS; RETROPERITONEAL ABSCESS; SINGLE DRUG DOSE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT RESPONSE; WOUND IRRIGATION; DRUG EFFECTS; ENDOCARDITIS, BACTERIAL; MICROBIOLOGY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; DAPTOMYCIN; DEBRIDEMENT; DRUG RESISTANCE, BACTERIAL; ENDOCARDITIS, BACTERIAL; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; OSTEOMYELITIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME; VANCOMYCIN;

EID: 84891386225     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt009     Document Type: Article

References (8)

1. Liu C, Bayer A, Cosgrove SE et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011; 52: e18-55.
2. Lefebvre M, Jacqueline C, Amador G et al. Efficacy of daptomycin combined with rifampicin for the treatment of experimental meticillinresistant Staphylococcus aureus (MRSA) acute osteomyelitis. Int J Antimicrob Agents 2010; 36: 542-4.
3. Rybak M, Lomaestro B, Rotschafer JC et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health-Syst Pharm 2009; 1: 82-98.
4. Hidayat LK, Hsu DI, Quist R et al. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections. Arch Intern Med 2006; 166: 2138-44.
5. Ho TT, Cadena J, Childs LM et al. Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy. J Antimicrob Chemother 2012; 67: 1267-70.
6. Jacqueline C. Efficacy of the new cephalosporin ceftaroline in the treatment of experimental methicillin-resistant Staphylococcus aureus acute osteomyelitis. J Antimicrob Chemother 2010; 65: 1749-52.
7. Boucher HW, Sakoulas G. Perspectives on daptomycin resistance, with emphasis on resistance in Staphylococcus aureus. Clin Infect Dis 2007; 45: 601-8.
8. Skiest DJ. Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin. J Clin Microbiol 2006; 44: 655-6.